GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
Series GSE139492 Query DataSets for GSE139492
Status Public on Oct 29, 2019
Title CD47 blockade augmentation of Trastuzumab antitumor efficacy dependent upon antibody-dependent-cellular-phagocytosis
Organism Mus musculus
Experiment type Expression profiling by high throughput sequencing
Summary Analysis of HER2 breast tumor immune infiltrates in mice treated with murine Trastuzumab and CD47 checkpoint blockade therapy
Overall design Single Cell RNA Seq (scRNAseq) was performed on endogenous HER2-driven breast cancer in transgenic mice. The goal of this experiment is to compare effects of different antibody therapy combinations on tumor macrophages transcriptome
Contributor(s) Tsao L, Agarwal P, Crosby EJ, Lyerly HK, Hartman ZC
Citation missing Has this study been published? Please login to update or notify GEO.
Submission date Oct 28, 2019
Last update date Oct 31, 2019
Contact name Zachary Conrad Hartman
Phone 919-684-9197
Organization name Duke University
Department Surgery
Lab Lyerly Lab
Street address Research Drive MSRB rm 414
City Durham
State/province NC
ZIP/Postal code 27710
Country USA
Platforms (2)
GPL21273 HiSeq X Ten (Mus musculus)
GPL24247 Illumina NovaSeq 6000 (Mus musculus)
Samples (13)
GSM4142329 Isotype antibody [UN_241A]
GSM4142330 Untreated [UN_698A]
GSM4142331 Untreated [UN_698B]
BioProject PRJNA579973
SRA SRP227233

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE139492_RAW.tar 997.8 Mb (http)(custom) TAR (of TSV)
SRA Run SelectorHelp
Raw data are available in SRA
Processed data provided as supplementary file

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap